PCI Biotech Holding ASA (PCIB) — Net Asset Quality Index
PCI Biotech Holding ASA (PCIB) has a Net Asset Quality Index of 67.6% as of June 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Nkr18.52 Million minus total liabilities of Nkr6.01 Million yields net assets of Nkr12.52 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read PCI Biotech Holding ASA (PCIB) total liabilities for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
PCI Biotech Holding ASA Net Asset Quality Index Over Time (2008–2024)
This chart shows how PCI Biotech Holding ASA's Net Asset Quality Index has evolved across 17 annual periods from 2008 to 2024. As of June 2025, the index stands at 67.6%, representing net assets of Nkr12.52 Million against total assets of Nkr18.52 Million NOK. For live market cap and overall valuation, see PCI Biotech Holding ASA (PCIB) market capitalisation.
Annual Net Asset Quality Index for PCI Biotech Holding ASA (2008–2024)
The table below presents the year-by-year Net Asset Quality Index for PCI Biotech Holding ASA from 2008 to 2024, covering 17 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check PCIB strategic asset allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (NOK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 75.1% | Nkr23.45 Million | Nkr31.21 Million | Nkr7.76 Million | ▼ -13.5 pp |
| 2023 | 88.6% | Nkr39.04 Million | Nkr44.05 Million | Nkr5.01 Million | ▼ -1.8 pp |
| 2022 | 90.4% | Nkr57.40 Million | Nkr63.48 Million | Nkr6.08 Million | ▲ +6.7 pp |
| 2021 | 83.7% | Nkr113.79 Million | Nkr135.98 Million | Nkr22.19 Million | ▼ -6.8 pp |
| 2020 | 90.5% | Nkr189.24 Million | Nkr209.12 Million | Nkr19.88 Million | ▲ +0.1 pp |
| 2019 | 90.4% | Nkr254.83 Million | Nkr282.03 Million | Nkr27.20 Million | ▼ -4.9 pp |
| 2018 | 95.2% | Nkr339.95 Million | Nkr357.06 Million | Nkr17.10 Million | ▲ +23.6 pp |
| 2017 | 71.6% | Nkr41.84 Million | Nkr58.44 Million | Nkr16.59 Million | ▲ +13.2 pp |
| 2016 | 58.4% | Nkr13.09 Million | Nkr22.40 Million | Nkr9.31 Million | ▼ -20.1 pp |
| 2015 | 78.5% | Nkr44.28 Million | Nkr56.40 Million | Nkr12.12 Million | ▲ +33.8 pp |
| 2014 | 44.7% | Nkr9.11 Million | Nkr20.38 Million | Nkr11.27 Million | ▼ -37.6 pp |
| 2013 | 82.3% | Nkr43.40 Million | Nkr52.74 Million | Nkr9.34 Million | ▼ -6.8 pp |
| 2012 | 89.1% | Nkr69.71 Million | Nkr78.20 Million | Nkr8.49 Million | ▼ -3.2 pp |
| 2011 | 92.4% | Nkr92.53 Million | Nkr100.17 Million | Nkr7.63 Million | ▲ +0.3 pp |
| 2010 | 92.0% | Nkr105.42 Million | Nkr114.54 Million | Nkr9.12 Million | ▲ +7.6 pp |
| 2009 | 84.5% | Nkr35.08 Million | Nkr41.53 Million | Nkr6.45 Million | ▼ -5.9 pp |
| 2008 | 90.3% | Nkr49.30 Million | Nkr54.58 Million | Nkr5.28 Million | — |